Association between Elevated Plasma Homocysteine and Low Skeletal Muscle Mass in Asymptomatic Adults

Background: Homocysteine has been drawing attention with a closed linkage with skeletal muscle. However, the association of hyperhomocysteinemia with decreased skeletal muscle mass remains unclear. We aimed to investigate the association of hyperhomocysteinemia with low skeletal muscle mass (LMM) in...

Full description

Saved in:
Bibliographic Details
Published inEndocrinology and metabolism (Seoul) Vol. 37; no. 2; pp. 333 - 343
Main Authors Choi, Jae-Hyeong, Seo, Jin-Woo, Lee, Mi-Yeon, Lee, Yong-Taek, Yoon, Kyung Jae, Park, Chul-Hyun
Format Journal Article
LanguageEnglish
Published Korea (South) Korean Endocrine Society 01.04.2022
대한내분비학회
Subjects
Online AccessGet full text
ISSN2093-596X
2093-5978
2093-5978
DOI10.3803/EnM.2021.1202

Cover

Abstract Background: Homocysteine has been drawing attention with a closed linkage with skeletal muscle. However, the association of hyperhomocysteinemia with decreased skeletal muscle mass remains unclear. We aimed to investigate the association of hyperhomocysteinemia with low skeletal muscle mass (LMM) in asymptomatic adults.Methods: This was a cross-sectional study of 114,583 community-dwelling adults without cancer, stroke, or cardiovascular diseases who underwent measurements of plasma homocysteine and body composition analysis from 2012 to 2018. Hyperhomocysteinemia was defined as >15 μmol/L. Skeletal muscle mass index (SMI) was calculated based on appendicular muscle mass (kg)/height (m)2. Participants were classified into three groups based on SMI: “normal,” “mildly low,” and “severely low.”Results: The prevalence of hyperhomocysteinemia was the highest in subjects with severely LMM (12.9%), followed by those with mildly LMM (9.8%), and those with normal muscle mass (8.5%) (P for trend <0.001). In a multivariable logistic regression model, hyperhomocysteinemia was significantly associated with having a mildly LMM (odds ratio [OR], 1.305; 95% confidence interval [CI], 1.224 to 1.392) and severely LMM (OR, 1.958; 95% CI, 1.667 to 2.286), respectively. One unit increment of log-transformed homocysteine was associated with 1.360 and 2.169 times higher risk of having mildly LMM and severely LMM, respectively.Conclusion: We demonstrated that elevated homocysteine has an independent association with LMM in asymptomatic adults, supporting that hyperhomocysteinemia itself can be a risk for decline in skeletal musculature.
AbstractList Background: Homocysteine has been drawing attention with a closed linkage with skeletal muscle. However, the association of hyperhomocysteinemia with decreased skeletal muscle mass remains unclear. We aimed to investigate the association of hyperhomocysteinemia with low skeletal muscle mass (LMM) in asymptomatic adults.Methods: This was a cross-sectional study of 114,583 community-dwelling adults without cancer, stroke, or cardiovascular diseases who underwent measurements of plasma homocysteine and body composition analysis from 2012 to 2018. Hyperhomocysteinemia was defined as >15 μmol/L. Skeletal muscle mass index (SMI) was calculated based on appendicular muscle mass (kg)/height (m)2. Participants were classified into three groups based on SMI: “normal,” “mildly low,” and “severely low.”Results: The prevalence of hyperhomocysteinemia was the highest in subjects with severely LMM (12.9%), followed by those with mildly LMM (9.8%), and those with normal muscle mass (8.5%) (P for trend <0.001). In a multivariable logistic regression model, hyperhomocysteinemia was significantly associated with having a mildly LMM (odds ratio [OR], 1.305; 95% confidence interval [CI], 1.224 to 1.392) and severely LMM (OR, 1.958; 95% CI, 1.667 to 2.286), respectively. One unit increment of log-transformed homocysteine was associated with 1.360 and 2.169 times higher risk of having mildly LMM and severely LMM, respectively.Conclusion: We demonstrated that elevated homocysteine has an independent association with LMM in asymptomatic adults, supporting that hyperhomocysteinemia itself can be a risk for decline in skeletal musculature.
Homocysteine has been drawing attention with a closed linkage with skeletal muscle. However, the association of hyperhomocysteinemia with decreased skeletal muscle mass remains unclear. We aimed to investigate the association of hyperhomocysteinemia with low skeletal muscle mass (LMM) in asymptomatic adults. This was a cross-sectional study of 114,583 community-dwelling adults without cancer, stroke, or cardiovascular diseases who underwent measurements of plasma homocysteine and body composition analysis from 2012 to 2018. Hyperhomocysteinemia was defined as >15 μmol/L. Skeletal muscle mass index (SMI) was calculated based on appendicular muscle mass (kg)/height (m)2. Participants were classified into three groups based on SMI: "normal," "mildly low," and "severely low." The prevalence of hyperhomocysteinemia was the highest in subjects with severely LMM (12.9%), followed by those with mildly LMM (9.8%), and those with normal muscle mass (8.5%) (P for trend <0.001). In a multivariable logistic regression model, hyperhomocysteinemia was significantly associated with having a mildly LMM (odds ratio [OR], 1.305; 95% confidence interval [CI], 1.224 to 1.392) and severely LMM (OR, 1.958; 95% CI, 1.667 to 2.286), respectively. One unit increment of log-transformed homocysteine was associated with 1.360 and 2.169 times higher risk of having mildly LMM and severely LMM, respectively. We demonstrated that elevated homocysteine has an independent association with LMM in asymptomatic adults, supporting that hyperhomocysteinemia itself can be a risk for decline in skeletal musculature.
Homocysteine has been drawing attention with a closed linkage with skeletal muscle. However, the association of hyperhomocysteinemia with decreased skeletal muscle mass remains unclear. We aimed to investigate the association of hyperhomocysteinemia with low skeletal muscle mass (LMM) in asymptomatic adults.BACKGROUNDHomocysteine has been drawing attention with a closed linkage with skeletal muscle. However, the association of hyperhomocysteinemia with decreased skeletal muscle mass remains unclear. We aimed to investigate the association of hyperhomocysteinemia with low skeletal muscle mass (LMM) in asymptomatic adults.This was a cross-sectional study of 114,583 community-dwelling adults without cancer, stroke, or cardiovascular diseases who underwent measurements of plasma homocysteine and body composition analysis from 2012 to 2018. Hyperhomocysteinemia was defined as >15 μmol/L. Skeletal muscle mass index (SMI) was calculated based on appendicular muscle mass (kg)/height (m)2. Participants were classified into three groups based on SMI: "normal," "mildly low," and "severely low."METHODSThis was a cross-sectional study of 114,583 community-dwelling adults without cancer, stroke, or cardiovascular diseases who underwent measurements of plasma homocysteine and body composition analysis from 2012 to 2018. Hyperhomocysteinemia was defined as >15 μmol/L. Skeletal muscle mass index (SMI) was calculated based on appendicular muscle mass (kg)/height (m)2. Participants were classified into three groups based on SMI: "normal," "mildly low," and "severely low."The prevalence of hyperhomocysteinemia was the highest in subjects with severely LMM (12.9%), followed by those with mildly LMM (9.8%), and those with normal muscle mass (8.5%) (P for trend <0.001). In a multivariable logistic regression model, hyperhomocysteinemia was significantly associated with having a mildly LMM (odds ratio [OR], 1.305; 95% confidence interval [CI], 1.224 to 1.392) and severely LMM (OR, 1.958; 95% CI, 1.667 to 2.286), respectively. One unit increment of log-transformed homocysteine was associated with 1.360 and 2.169 times higher risk of having mildly LMM and severely LMM, respectively.RESULTSThe prevalence of hyperhomocysteinemia was the highest in subjects with severely LMM (12.9%), followed by those with mildly LMM (9.8%), and those with normal muscle mass (8.5%) (P for trend <0.001). In a multivariable logistic regression model, hyperhomocysteinemia was significantly associated with having a mildly LMM (odds ratio [OR], 1.305; 95% confidence interval [CI], 1.224 to 1.392) and severely LMM (OR, 1.958; 95% CI, 1.667 to 2.286), respectively. One unit increment of log-transformed homocysteine was associated with 1.360 and 2.169 times higher risk of having mildly LMM and severely LMM, respectively.We demonstrated that elevated homocysteine has an independent association with LMM in asymptomatic adults, supporting that hyperhomocysteinemia itself can be a risk for decline in skeletal musculature.CONCLUSIONWe demonstrated that elevated homocysteine has an independent association with LMM in asymptomatic adults, supporting that hyperhomocysteinemia itself can be a risk for decline in skeletal musculature.
Background: Homocysteine has been drawing attention with a closed linkage with skeletal muscle. However, the association of hyperhomocysteinemia with decreased skeletal muscle mass remains unclear. We aimed to investigate the association of hyperhomocysteinemia with low skeletal muscle mass (LMM) in asymptomatic adults. Methods: This was a cross-sectional study of 114,583 community-dwelling adults without cancer, stroke, or cardiovascular diseaseswho underwent measurements of plasma homocysteine and body composition analysis from 2012 to 2018. Hyperhomocysteinemiawas defined as >15 µmol/L. Skeletal muscle mass index (SMI) was calculated based on appendicular muscle mass (kg)/height (m)2. Participants were classified into three groups based on SMI: “normal,” “mildly low,” and “severely low.”Results: The prevalence of hyperhomocysteinemia was the highest in subjects with severely LMM (12.9%), followed by those withmildly LMM (9.8%), and those with normal muscle mass (8.5%) (P for trend <0.001). In a multivariable logistic regression model,hyperhomocysteinemia was significantly associated with having a mildly LMM (odds ratio [OR], 1.305; 95% confidence interval[CI], 1.224 to 1.392) and severely LMM (OR, 1.958; 95% CI, 1.667 to 2.286), respectively. One unit increment of log-transformedhomocysteine was associated with 1.360 and 2.169 times higher risk of having mildly LMM and severely LMM, respectively. Conclusion: We demonstrated that elevated homocysteine has an independent association with LMM in asymptomatic adults, supporting that hyperhomocysteinemia itself can be a risk for decline in skeletal musculature. KCI Citation Count: 0
Author Seo, Jin-Woo
Park, Chul-Hyun
Choi, Jae-Hyeong
Lee, Yong-Taek
Yoon, Kyung Jae
Lee, Mi-Yeon
AuthorAffiliation 3 Medical Research Institute, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
2 Division of Biostatistics, Department of R&D Management, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
1 Department of Physical and Rehabilitation Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
AuthorAffiliation_xml – name: 3 Medical Research Institute, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
– name: 1 Department of Physical and Rehabilitation Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
– name: 2 Division of Biostatistics, Department of R&D Management, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
Author_xml – sequence: 1
  givenname: Jae-Hyeong
  orcidid: 0000-0002-4945-4877
  surname: Choi
  fullname: Choi, Jae-Hyeong
– sequence: 2
  givenname: Jin-Woo
  orcidid: 0000-0003-0004-1913
  surname: Seo
  fullname: Seo, Jin-Woo
– sequence: 3
  givenname: Mi-Yeon
  surname: Lee
  fullname: Lee, Mi-Yeon
– sequence: 4
  givenname: Yong-Taek
  surname: Lee
  fullname: Lee, Yong-Taek
– sequence: 5
  givenname: Kyung Jae
  orcidid: 0000-0002-2765-4309
  surname: Yoon
  fullname: Yoon, Kyung Jae
– sequence: 6
  givenname: Chul-Hyun
  orcidid: 0000-0002-9897-6612
  surname: Park
  fullname: Park, Chul-Hyun
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35144330$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002834865$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNptks9vFCEUxyemxtbao1fD0ZjsCsMwwMVk06x2k91otCbeCANvKl0G2oFts_-97G7bWCMH3gt83-fx4_u6OgoxQFW9JXhKBaYf52E1rXFNpqTML6qTGks6YZKLo6e8_XVcnaV0jcsQoiE1eVUdU0aahlJ8UtlZStE4nV0MqIN8DxDQ3MOdzmDRN6_ToNFFHKLZpgwuANLBomW8Rz_W4CFrj1abZDyglU4JuYBmaTvc5DgUpEEzu_E5vale9tonOHuIp9XPz_PL84vJ8uuXxflsOTGNEHkC0GjMW26lxbhvhWmkMZIAIZ3u6kZyy0HytpdMMiF2GWWdkQY6jBkTnJ5WHw7cMPZqbZyK2u3jVVTrUc2-Xy4UwbhuOW-LeHEQ26iv1c3oBj1u9xX7hTheKT2WO3hQjRaaYdEawvvG1q00fUMo76zhtAcDhfXpwLrZdANYAyGP2j-DPt8J7nc51J2SWBBKSAG8fwCM8XYDKavBJQPe6wBxk1Td1oJiwhgr0nd_93pq8vinRUAPAjPGlEbolXF5_8GltfPlBdTOPKqYR-3Mo3bmKVWTf6oewf_X_wGoWMWP
CitedBy_id crossref_primary_10_2147_IJGM_S416230
crossref_primary_10_3389_fgene_2022_1051047
crossref_primary_10_1186_s12877_022_03632_0
crossref_primary_10_4103_bbrj_bbrj_234_24
crossref_primary_10_3390_nu16193322
crossref_primary_10_1007_s11010_023_04761_9
crossref_primary_10_1038_s41598_024_76693_3
crossref_primary_10_3389_fnut_2024_1369331
crossref_primary_10_1038_s41598_022_16401_1
Cites_doi 10.1152/ajpendo.00301.2007
10.1016/j.exger.2020.110832
10.1515/cclm.2004.072
10.1152/ajpheart.00099.2015
10.1111/ggi.12723
10.1139/cjpp-2020-0093
10.1007/s40520-016-0717-0
10.1016/j.gerinurse.2014.03.001
10.1038/ejcn.2011.151
10.1146/annurev.nu.12.070192.001431
10.1016/j.amjcard.2016.01.033
10.1097/bor.0b013e328358d59b
10.3945/ajcn.2009.28256
10.1590/s0100-879x2009007500021
10.1038/ejcn.2013.97
10.1016/j.arr.2018.10.010
10.1016/j.ejim.2014.04.011
10.1053/meta.2001.23286
10.1002/jcb.25841
10.1007/s12272-018-1016-4
10.1093/qjmed/hcn112
10.1155/2019/9276097
10.3390/ijms140715074
10.1038/s41598-020-76185-0
10.1007/s11864-019-0691-9
10.1007/s12603-013-0336-9
10.1016/s0140-6736(19)31138-9
10.1046/j.1532-5415.2002.50216.x
10.1016/j.bbadis.2015.01.008
10.12965/jer.1836268.134
10.1093/ageing/afz046
10.1016/j.jstrokecerebrovasdis.2020.105259
10.1001/jamasurg.2020.2497
10.1093/ajcn/88.3.738
10.1016/j.tipsro.2020.10.001
10.1056/nejm199801013380101
10.1016/j.jamda.2014.11.011
10.1093/gerona/glx161
10.3389/fnut.2019.00049
10.1038/s12276-019-0216-4
10.1016/j.jamda.2014.02.005
10.1136/bmjopen-2017-021232
10.1787/5js1qwkz2p9s-en
10.1111/resp.13877
10.1007/s13539-012-0078-2
ContentType Journal Article
Copyright Copyright © 2022 Korean Endocrine Society 2022
Copyright_xml – notice: Copyright © 2022 Korean Endocrine Society 2022
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
ACYCR
DOI 10.3803/EnM.2021.1202
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
Korean Citation Index
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList CrossRef

MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 2093-5978
EndPage 343
ExternalDocumentID oai_kci_go_kr_ARTI_10026776
oai_doaj_org_article_4a8a5086c17f4d269cf4137bdc73fece
PMC9081311
35144330
10_3803_EnM_2021_1202
Genre Journal Article
GrantInformation_xml – fundername: National Research Foundation of Korea
  grantid: 2020R1F1A107615712
– fundername: Ministry of Science and ICT
GroupedDBID 5-W
53G
5VS
8JR
8XY
AAYXX
ABDBF
ACUHS
ADBBV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EF.
GROUPED_DOAJ
HYE
HZB
KQ8
M48
OK1
PGMZT
RPM
ADRAZ
CGR
CUY
CVF
ECM
EIF
IPNFZ
NPM
RIG
7X8
5PM
ACYCR
ID FETCH-LOGICAL-c488t-ee4a0767d9d00f68c49cc91e11bab2497d7e976f959588976f35bc9ceb0055873
IEDL.DBID M48
ISSN 2093-596X
2093-5978
IngestDate Sun Mar 09 07:51:27 EDT 2025
Wed Aug 27 01:27:25 EDT 2025
Thu Aug 21 17:03:19 EDT 2025
Thu Jul 10 19:19:55 EDT 2025
Tue Apr 29 09:42:36 EDT 2025
Tue Jul 01 01:37:49 EDT 2025
Thu Apr 24 22:53:39 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Muscle, skeletal
Homocysteine
Sarcopenia
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c488t-ee4a0767d9d00f68c49cc91e11bab2497d7e976f959588976f35bc9ceb0055873
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
ORCID 0000-0002-2765-4309
0000-0002-9897-6612
0000-0002-4945-4877
0000-0003-0004-1913
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3803/EnM.2021.1202
PMID 35144330
PQID 2628301555
PQPubID 23479
PageCount 11
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_10026776
doaj_primary_oai_doaj_org_article_4a8a5086c17f4d269cf4137bdc73fece
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9081311
proquest_miscellaneous_2628301555
pubmed_primary_35144330
crossref_citationtrail_10_3803_EnM_2021_1202
crossref_primary_10_3803_EnM_2021_1202
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-04-01
PublicationDateYYYYMMDD 2022-04-01
PublicationDate_xml – month: 04
  year: 2022
  text: 2022-04-01
  day: 01
PublicationDecade 2020
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Endocrinology and metabolism (Seoul)
PublicationTitleAlternate Endocrinol Metab (Seoul)
PublicationYear 2022
Publisher Korean Endocrine Society
대한내분비학회
Publisher_xml – name: Korean Endocrine Society
– name: 대한내분비학회
References ref13
ref12
ref15
ref14
ref11
ref10
ref17
ref16
ref19
ref18
Abai (ref30) 2021
(ref22) 2002
ref50
ref46
ref45
ref48
ref47
ref42
ref41
ref44
ref43
(ref49) 2001
ref8
ref7
ref9
ref4
ref3
ref6
ref5
ref40
ref35
ref34
ref37
ref36
(ref28) 2020
ref31
ref33
ref32
ref2
ref39
ref38
Chen (ref1) 2020
ref24
ref23
ref26
ref25
ref20
ref21
ref27
ref29
References_xml – ident: ref44
  doi: 10.1152/ajpendo.00301.2007
– ident: ref15
  doi: 10.1016/j.exger.2020.110832
– ident: ref42
  doi: 10.1515/cclm.2004.072
– ident: ref37
  doi: 10.1152/ajpheart.00099.2015
– year: 2021
  ident: ref30
– start-page: 89
  volume-title: Biomarkers and surrogate endpoints: preferred definitions and conceptual framework
  year: 2001
  ident: ref49
– ident: ref9
  doi: 10.1111/ggi.12723
– ident: ref39
  doi: 10.1139/cjpp-2020-0093
– ident: ref50
  doi: 10.1007/s40520-016-0717-0
– ident: ref2
  doi: 10.1016/j.gerinurse.2014.03.001
– ident: ref12
  doi: 10.1038/ejcn.2011.151
– year: 2020
  ident: ref28
– ident: ref29
  doi: 10.1146/annurev.nu.12.070192.001431
– ident: ref5
  doi: 10.1016/j.amjcard.2016.01.033
– ident: ref18
  doi: 10.1097/bor.0b013e328358d59b
– ident: ref4
  doi: 10.3945/ajcn.2009.28256
– ident: ref34
  doi: 10.1590/s0100-879x2009007500021
– ident: ref36
  doi: 10.1038/ejcn.2013.97
– ident: ref41
  doi: 10.1016/j.arr.2018.10.010
– ident: ref23
  doi: 10.1016/j.ejim.2014.04.011
– ident: ref40
  doi: 10.1053/meta.2001.23286
– ident: ref35
  doi: 10.1002/jcb.25841
– ident: ref11
  doi: 10.1007/s12272-018-1016-4
– ident: ref43
  doi: 10.1093/qjmed/hcn112
– start-page: 2015
  volume-title: Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis
  year: 2002
  ident: ref22
– ident: ref13
  doi: 10.1155/2019/9276097
– ident: ref45
  doi: 10.3390/ijms140715074
– ident: ref20
  doi: 10.1038/s41598-020-76185-0
– ident: ref25
  doi: 10.1007/s11864-019-0691-9
– ident: ref17
  doi: 10.1007/s12603-013-0336-9
– ident: ref21
  doi: 10.1016/s0140-6736(19)31138-9
– ident: ref32
  doi: 10.1046/j.1532-5415.2002.50216.x
– ident: ref38
  doi: 10.1016/j.bbadis.2015.01.008
– ident: ref46
  doi: 10.12965/jer.1836268.134
– ident: ref47
  doi: 10.1093/ageing/afz046
– ident: ref6
  doi: 10.1016/j.jstrokecerebrovasdis.2020.105259
– ident: ref8
  doi: 10.1001/jamasurg.2020.2497
– ident: ref16
  doi: 10.1093/ajcn/88.3.738
– ident: ref24
  doi: 10.1016/j.tipsro.2020.10.001
– ident: ref19
  doi: 10.1056/nejm199801013380101
– ident: ref33
  doi: 10.1016/j.jamda.2014.11.011
– ident: ref14
  doi: 10.1093/gerona/glx161
– start-page: 300
  volume-title: Asian Working Group for Sarcopenia: 2019 consensus date on sarcopenia diagnosis and treatment
  year: 2020
  ident: ref1
– ident: ref10
  doi: 10.3389/fnut.2019.00049
– ident: ref31
  doi: 10.1038/s12276-019-0216-4
– ident: ref3
  doi: 10.1016/j.jamda.2014.02.005
– ident: ref27
  doi: 10.1136/bmjopen-2017-021232
– ident: ref26
  doi: 10.1787/5js1qwkz2p9s-en
– ident: ref7
  doi: 10.1111/resp.13877
– ident: ref48
  doi: 10.1007/s13539-012-0078-2
SSID ssj0000884121
Score 2.2920945
Snippet Background: Homocysteine has been drawing attention with a closed linkage with skeletal muscle. However, the association of hyperhomocysteinemia with decreased...
Homocysteine has been drawing attention with a closed linkage with skeletal muscle. However, the association of hyperhomocysteinemia with decreased skeletal...
Background Homocysteine has been drawing attention with a closed linkage with skeletal muscle. However, the association of hyperhomocysteinemia with decreased...
SourceID nrf
doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 333
SubjectTerms Adult
Cross-Sectional Studies
Homocysteine
Humans
Hyperhomocysteinemia - epidemiology
muscle
Muscle, Skeletal
Odds Ratio
Original
sarcopenia
skeletal
내과학
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQnrggEK_AsjICcSJsHDt-HAvqqiCKkGCl3izHD6i6TVZ9gPbfM5OkVYtAXDglip3IGY893yQz3xDyUsUQuJQ6jzpWOVJ250akOpecC6fAHkeDicLTT3JyKT7MqtlBqS-MCevpgXvBnQunHYAI6ZlKIpTS-AT7rqqDVzxFH3H3LUxx4Ex1e7DWgnVJV9DI88rIWU-wyXXBz8fNFDzDkr1h5fA5ZWeQOt5-MDPNKv0Jcv4eOXlgii7ukjsDhqSjfuz3yK3Y3CfhQNB0iL6i46v4A8BkoJ8BJC8dnbTL1iN3M2BL6ppAP7Y_6ZcFmB7A4HS6XcPz6BTwNJ03dLS-WV5v2o7TlY6Qp2P9gFxejL--m-RDCYXcw8rc5DEKVyipgglFkaT2wnhvWGSsdjV4XiqoCIAkmcpUWuMZr2pvPFYUqiqt-ENy0rRNfExo0qF0sk7wgEIkWRrnNXMhmrL0GlBfRl7v5Gj9wC-OZS6uLPgZKHYLYrcodotiz8irfffrnljjbx3f4qTsOyEfdncBtMQOWmL_pSUZeQFTahd-3t2Px2-tXawseA3vkbe5lErJjDzfTbmFVYa_TlwT2-3alhKJ0gB7VRl51KvAfkCYCyE4LzKijpTjaMTHLc38e8fkbQCQccae_I9XfEpul5ia0UUVnZKTzWobnwFg2tRn3dr4BUm1Etw
  priority: 102
  providerName: Directory of Open Access Journals
Title Association between Elevated Plasma Homocysteine and Low Skeletal Muscle Mass in Asymptomatic Adults
URI https://www.ncbi.nlm.nih.gov/pubmed/35144330
https://www.proquest.com/docview/2628301555
https://pubmed.ncbi.nlm.nih.gov/PMC9081311
https://doaj.org/article/4a8a5086c17f4d269cf4137bdc73fece
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002834865
Volume 37
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Endocrinology and Metabolism, 2022, 37(2), , pp.333-343
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lj9MwELbQcuGCQLzCY2UE4kSWxE78OCBUUFcFUYQElXqzHNvZrdomS9MC---ZcbNlC4vEKVHiWNbnmcw3if0NIc9l8J4LodKgQpmiZHeqi7pKBeeFlRCPg8aNwuNPYjQpPkzL6W9JoR7A7srUDutJTVaLo5_fzt-Aw7_GjFNl_NWwGUOix_KjnKGs5PX4qwhX8fVMP76UlSryuAuLQQ6fllpMt4qbf_ewF6GikD_EnWZVX8VB_1xKeSk2Hd8iN3tSSQdbK7hNroXmDvGXkKf9ciw6XITvwC49_QyseWnpqF22DsWcgWxS23j6sf1Bv8whFgEedLzpoD86BoJNZw0ddOfLs3UbRV7pAIU7urtkcjz8-m6U9jUVUgeuuk5DKGwmhfTaZ1ktlCu0czoPeV7ZClIx6WUAhlLrUpdK4RkvK6cdlhgqSyX5PXLQtE14QGitPLOiqqGDrKgF09ap3PqgGXMKaGBCXl7gaFwvOI51LxYGEg-E3QDsBmE3CHtCXuyan22VNv7V8C1Oyq4RCmTHC-3qxPT-ZgqrLHBP4XJZF54J7WqwCll5J3kdXEjIM5hSM3ez-DweT1ozXxlII96jkDMTUoqEPL2YcgNuh_9SbBPaTWeYQOU0IGNlQu5vTWA3INwcUXCeJUTuGcfeiPfvNLPTKO2tgaHxPH_4v1g8IjcY7seIS4kek4P1ahOeAEtaV4fx68Jh9IJff9wPWA
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+Elevated+Plasma+Homocysteine+and+Low+Skeletal+Muscle+Mass+in+Asymptomatic+Adults&rft.jtitle=Endocrinology+and+metabolism+%28Seoul%29&rft.au=Choi%2C+Jae-Hyeong&rft.au=Seo%2C+Jin-Woo&rft.au=Lee%2C+Mi-Yeon&rft.au=Lee%2C+Yong-Taek&rft.date=2022-04-01&rft.issn=2093-596X&rft.eissn=2093-5978&rft.volume=37&rft.issue=2&rft.spage=333&rft.epage=343&rft_id=info:doi/10.3803%2FEnM.2021.1202&rft.externalDBID=n%2Fa&rft.externalDocID=10_3803_EnM_2021_1202
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2093-596X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2093-596X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2093-596X&client=summon